...
首页> 外文期刊>The journal of clinical investigation >Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis
【24h】

Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis

机译:小鼠体内胰高血糖素和GLP-1受体的双重消除揭示了肠降血糖素轴的可塑性

获取原文
           

摘要

Disordered glucagon secretion contributes to the symptoms of diabetes, and reduced glucagon action is known to improve glucose homeostasis. In mice, genetic deletion of the glucagon receptor ( Gcgr ) results in increased levels of the insulinotropic hormone glucagon-like peptide 1 (GLP-1), which may contribute to the alterations in glucose homeostasis observed in Gcgr~(–/–) mice. Here, we assessed the contribution of GLP-1 receptor (GLP-1R) signaling to the phenotype of Gcgr~(–/–) mice by generating Gcgr~(–/–)Glp1r~(–/–) mice. Although insulin sensitivity was similar in all genotypes, fasting glucose was increased in Gcgr~(–/–)Glp1r~(–/–) mice. Elimination of the Glp1r normalized gastric emptying and impaired intraperitoneal glucose tolerance in Gcgr~(–/–) mice. Unexpectedly, deletion of Glp1r in Gcgr~(–/–) mice did not alter the improved oral glucose tolerance and increased insulin secretion characteristic of that genotype. Although Gcgr~(–/–)Glp1r~(–/–) islets exhibited increased sensitivity to the incretin glucose-dependent insulinotropic polypeptide (GIP), mice lacking both Glp1r and the GIP receptor ( Gipr ) maintained preservation of the enteroinsular axis following reduction of Gcgr signaling. Moreover, Gcgr~(–/–)Glp1r~(–/–) islets expressed increased levels of the cholecystokinin A receptor ( Cckar ) and G protein–coupled receptor 119 ( Gpr119 ) mRNA transcripts, and Gcgr~(–/–)Glp1r~(–/–) mice exhibited increased sensitivity to exogenous CCK and the GPR119 agonist {"type":"entrez-nucleotide","attrs":{"text":"AR231453","term_id":"27272544","term_text":"AR231453"}}AR231453. Our data reveal extensive functional plasticity in the enteroinsular axis via induction of compensatory mechanisms that control nutrient-dependent regulation of insulin secretion.
机译:胰高血糖素分泌紊乱加剧了糖尿病的症状,已知降低的胰高血糖素作用可改善葡萄糖稳态。在小鼠中,胰高血糖素受体(Gcgr)的基因缺失导致促胰岛素激素胰高血糖素样肽1(GLP-1)水平升高,这可能有助于在Gcgr〜(– / –)小鼠中观察到葡萄糖稳态的改变。 。在这里,我们通过产生Gcgr〜(– / –)Glp1r〜(– / –)小鼠来评估GLP-1受体(GLP-1R)信号传导对Gcgr〜(– / –)小鼠表型的贡献。尽管所有基因型的胰岛素敏感性相似,但Gcgr〜(– / –)Glp1r〜(– / –)小鼠的空腹血糖升高。在Gcgr〜(– / –)小鼠中,消除了Glp1r可使胃排空正常化,并损害腹膜内葡萄糖耐量。出乎意料的是,删除Gcgr〜(– / –)小鼠中的Glp1r不会改变该基因型的口服葡萄糖耐量改善和胰岛素分泌特征增加。尽管Gcgr〜(– / –)Glp1r〜(– / –)胰岛对肠降血糖素葡萄糖依赖性促胰岛素多肽(GIP)的敏感性增加,但是缺乏Glp1r和GIP受体(Gipr)的小鼠在还原后仍保持肠小肠轴Gcgr信号传递。此外,Gcgr〜(– / –)Glp1r〜(– / –)胰岛表达的胆囊收缩素A受体(Cckar)和G蛋白偶联受体119(Gpr119)mRNA转录水平以及Gcgr〜(– / –)Glp1r 〜(– / –)小鼠对外源CCK和GPR119激动剂{“ type”:“ entrez-nucleotide”,“ attrs”:{“ text”:“ AR231453”,“ term_id”:“ 27272544”,“ term_text“:” AR231453“}} AR231453。我们的数据通过诱导补偿机制控制胰岛素分泌的营养依赖性调节,揭示了肠小肠轴广泛的功能可塑性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号